Skip to content

US · HCA · MEDICAL - CARE FACILITIES

HCA Healthcare, Inc. (HCA) intrinsic value and stock valuation

$475.57as of 2026-11-21 · Mkt cap 88.69B

Data updated · price as of 2026-11-21

UndervaluedIC value is 20–50% above the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

HCA Healthcare, Inc. DCF and intrinsic value

InvestorsCraft values HCA with the Chepakovich two-stage DCF model — currently rated undervalued. How the model works · Run your own DCF prefilled from HCA’s statements →

HCA Healthcare, Inc. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Care Facilities Nashville, TN 37203 hcahealthcare.com

How the business is doing

Fiscal 2011–2025, USD

Revenue
$75.6B+8% 5y CAGRd
20112025
Net income
$6.78B+12.6% 5y CAGRd
20112025
Free cash flow
$7.69B+3.8% 5y CAGRd
20112025
Total equity
-$-2.77B
20112025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2011–2025, USD
20252024202320222021
Revenue$75.6B$70.6B$65B$60.2B$58.8B
Operating income$12B$10.5B$9.63B$9.05B$9.68B
Net income$6.78B$5.76B$5.24B$5.64B$6.96B
EPSd$29.4M$22M$19M$19.2M$21.2M
Operating cash flow$12.6B$10.5B$9.43B$8.52B$8.96B
Capital expenditure-$-4.94B-$-4.88B-$-4.74B-$-4.4B-$-3.58B
Free cash flow$7.69B$5.64B$4.69B$4.13B$5.38B
Total assets$60.7B$59.5B$56.2B$52.4B$50.7B
Total debt$50.2B$45.2B$41.9B$40.2B$36.7B
Net debt$49.2B$43.3B$40.9B$39.3B$35.3B
Total equity-$-2.77B$555M$1.06B-$-73M$1.49B
Cash and short-term investments$1.04B$2.02B$935M$908M$1.45B
Income statement
20252024202320222021
Revenue$75.6B$70.6B$65B$60.2B$58.8B
Cost of revenue$44.2B$41.9B$39.4B$37.1B$36.3B
Gross profit$31.4B$28.7B$25.6B$23.2B$22.5B
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$8B$31.2B$29.5B$27.7B$26.8B
Other expenses$11.4B-$-13.04B-$-13.54B-$-13.56B-$-13.97B
Operating expenses$19.4B$18.1B$16B$14.1B$12.8B
Cost and expenses$63.6B$60.1B$55.3B$51.2B$49.1B
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$2.25B$2.06B$1.94B$1.74B$1.53B
Depreciation and amortization$3.52B$3.31B$3.08B$2.97B$2.85B
Ebitda$15.6B$13.9B$12.7B$13.3B$14.3B
Operating income$12B$10.5B$9.63B$9.05B$9.68B
Total other income/expenses, net-$-2.13B-$-2.02B-$-1.92B-$-473M$155M
Income before tax$9.83B$8.52B$7.71B$8.58B$9.83B
Income tax expense$2.05B$1.87B$1.62B$1.75B$2.11B
Net income$6.78B$5.76B$5.24B$5.64B$6.96B
Weighted average shares outstanding$230.7M$258.6M$272.4M$290.4M$323.3M
Weighted average diluted shares outstanding$230.7M$261.8M$276.4M$294.7M$328.8M
Balance sheet
20252024202320222021
Cash and short-term investments$1.04B$2.02B$935M$908M$1.45B
Net receivables$10.9B$10.8B$9.96B$8.89B$8.1B
Inventory$1.65B$1.74B$2.02B$2.07B$1.99B
Total current assets$13.6B$16.4B$14.9B$13.6B$13.5B
Property, plant and equipment, net$31.1B$31.5B$29.9B$27.6B$26.2B
Goodwill and intangible assets$10.3B$10.1B$9.95B$9.65B$9.54B
Long-term investments$633M$1.23B$1.23B$1.2B$886M
Total non-current assets$47.2B$43.1B$41.3B$38.8B$37.2B
Total assets$60.7B$59.5B$56.2B$52.4B$50.7B
Accounts payable$4.66B$4.28B$4.23B$4.24B$4.11B
Short-term debt$6.74B$5.04B$2.79B$734M$629M
Deferred revenue$0.00$0.00$0.00$0.00$0.00
Total current liabilities$16.4B$15.2B$12.7B$9.9B$9.58B
Long-term debt$43.5B$40.2B$39.1B$39.5B$36.1B
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$47.1B$43.8B$42.5B$42.6B$39.7B
Capital lease obligations$1.85B$2.21B$2.27B$2.7B$2.72B
Total liabilities$63.5B$59B$55.2B$52.5B$49.3B
Common stock$2M$3M$3M$3M$3M
Retained earnings-$-5.72B-$-2.12B-$-1.35B-$-2.28B-$-532M
Accumulated other comprehensive income (loss)-$-305M-$-387M-$-425M-$-490M-$-404M
Total equity-$-2.77B$555M$1.06B-$-73M$1.49B
Total investments$633M$1.32B$1.23B$1.2B$886M
Total debt$50.2B$45.2B$41.9B$40.2B$36.7B
Net debt$49.2B$43.3B$40.9B$39.3B$35.3B
Cash flow statement
20252024202320222021
Net income$6.78B$6.66B$5.24B$6.83B$7.72B
Depreciation and amortization$3.52B$3.31B$3.08B$2.97B$2.85B
Stock-based compensation$0.00$360M$0.00$341M$440M
Change in working capital$728M-$-106M-$-457M-$-1.15B-$-503M
Accounts receivable-$-94M-$-799M-$-935M-$-797M-$-962M
Inventory-$-154M$334M-$-126M-$-59M-$-540M
Accounts payable$666M$359M$604M-$-296M$999M
Net cash provided by operating activities$12.6B$10.5B$9.43B$8.52B$8.96B
Investments in property, plant and equipment-$-4.94B-$-4.88B-$-4.74B-$-4.4B-$-3.58B
Acquisitions, net-$-128M$62M-$-442M$1.01B$1.06B
Net cash used for investing activities-$-4.99B-$-4.93B-$-5.32B-$-3.39B-$-2.64B
Common stock issued$0.00$0.00$0.00$0.00$0.00
Common stock repurchased-$-10.07B-$-6.04B-$-3.81B-$-7B-$-8.22B
Dividends paid-$-679M-$-690M-$-661M-$-653M-$-624M
Net cash used for financing activities-$-8.55B-$-4.58B-$-4.09B-$-5.66B-$-6.66B
Net change in cash-$-893M$998M$27M-$-543M-$-342M
Cash at end of period$1.04B$1.93B$935M$908M$1.45B
Operating cash flow$12.6B$10.5B$9.43B$8.52B$8.96B
Capital expenditure-$-4.94B-$-4.88B-$-4.74B-$-4.4B-$-3.58B
Free cash flow$7.69B$5.64B$4.69B$4.13B$5.38B
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About HCA Healthcare, Inc.

        HCA Healthcare, Inc., operating through its subsidiaries, delivers a comprehensive array of healthcare services throughout the United States. The organization manages a network of general and acute care hospitals that provide a full spectrum of medical and surgical care, encompassing inpatient services, intensive care, cardiac treatment, diagnostic procedures, and emergency services. These hospitals additionally offer a broad range of outpatient care, such as ambulatory surgery, laboratory testing, radiology, respiratory therapy, cardiology, and physical therapy. Beyond its hospital infrastructure, HCA Healthcare operates numerous specialized outpatient facilities. These include standalone ambulatory surgery centers, dedicated emergency care facilities, urgent care clinics, walk-in clinics, advanced diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology treatment facilities, physician practices, and various other healthcare sites. Furthermore, the company oversees psychiatric hospitals, which offer diverse therapeutic programs. These services cater to child, adolescent, and adult psychiatric care, alongside adolescent and adult alcohol and drug abuse treatment and counseling. As of December 31, 2021, HCA Healthcare's extensive portfolio included 182 hospitals, specifically 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals. Its network also featured 125 freestanding surgery centers and 21 freestanding endoscopy centers, all distributed across 20 states and England. Founded in 1968 and formerly known as HCA Holdings, Inc., the company's corporate headquarters are situated in Nashville, Tennessee.

        CEO
        Samuel N. Hazen
        Employees
        320K
        Beta
        1.13

        Included in

        Explore

        Frequently asked questions

        What is the intrinsic value of HCA Healthcare, Inc. (HCA)?

        HCA Healthcare, Inc. (HCA) is currently undervalued based on the InvestorsCraft IC model — IC value is 20–50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is HCA undervalued?

        HCA trades at a price of $475.57 (Nov 21, 2026): undervalued — IC value is 20–50% above the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.